TABLE 4.
The effects of propofol on the prognosis of cancer patients compared with volatile anaesthesia
| Type of study | Cancer types | Volatile anaesthesia | Outcomes | Ref. |
|---|---|---|---|---|
| Retrospective | Breast cancer | Desflurane or sevoflurane | No difference | 11, 12 |
| Retrospective | Non‐small cell lung cancer | Sevoflurane | No difference | 13 |
| Retrospective | High‐grade glioma | Sevoflurane | No difference | 14 |
| Retrospective | Gastric cancer | Desflurane or sevoflurane | No difference | 15 |
| Prospective | Breast cancer | Sevoflurane | No difference | 16 |
| Retrospective | Oesophageal cancer | Isoflurane, sevoflurane or desflurane | Better OS and RFS | 4 |
| Retrospective | Gastric cancer | Sevoflurane | Better OS | 5 |
| Retrospective | Colon cancer | Desflurane | Better OS and DFS; less postoperative metastasis | 6 |
| Retrospective | Hepatocellular carcinoma | Desflurane | Better OS | 7 |
| Retrospective | Cholangiocarcinoma | Desflurane | Better survival and less postoperative metastases | 8 |
| Prospective | Bladder cancer | Sevoflurane | Longer DFS | 2 |
Abbreviations: DFS, disease‐free survival; OS, overall survival; RFS, recurrence‐free survival.